‘Safer’ CRISPR: Base Editing Breaks Through in the Clinic as Beam, Verve Advance

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative to conventional CRISPR. Clinical results have so far been promising.

Scroll to Top